Insulin Delivery (OmniPod)

Insulet Corporation

Insulet Corporation, headquartered in Acton, Massachusetts, manufactures the OmniPod tubeless insulin management system, a wearable pod-based insulin delivery device that is the world's first truly tubeless insulin pump. Unlike traditional tethered insulin pumps, the OmniPod adheres directly to the skin and communicates wirelessly with a controller, eliminating the infusion set and pump body worn by conventional pump users. Insulet collaborates with academic diabetes centres on the OmniPod 5 automated insulin delivery system, which integrates with the Dexcom G6 CGM to form a closed-loop artificial pancreas. Research partnerships focus on control algorithms for hybrid closed-loop insulin delivery, glucose prediction models, and remote monitoring of glycaemic control in paediatric and elderly populations. Insulet funds investigator-initiated research at academic diabetes research centres in the US and Europe.